Corteva (NYSE:CTVA) Given New $89.00 Price Target at Oppenheimer

Corteva (NYSE:CTVA) had its price objective hoisted by Oppenheimer from $86.00 to $89.00 in a research note released on Wednesday morning,Benzinga reports. The firm currently has an outperform rating on the stock.

A number of other equities analysts have also recently weighed in on the company. UBS Group increased their price target on Corteva from $80.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, April 9th. Mizuho increased their price target on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Berenberg Bank increased their target price on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. Citigroup increased their target price on Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $84.90.

Corteva Stock Performance

NYSE CTVA opened at $79.19 on Wednesday. The stock has a market cap of $53.16 billion, a PE ratio of 50.12, a P/E/G ratio of 2.75 and a beta of 0.68. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. Corteva has a twelve month low of $60.53 and a twelve month high of $85.63. The stock has a fifty day simple moving average of $79.88 and a 200-day simple moving average of $71.43.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s revenue was down 1.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts anticipate that Corteva will post 3.63 earnings per share for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were paid a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 45.57%.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.15% of the company’s stock.

Institutional Investors Weigh In On Corteva

Hedge funds and other institutional investors have recently made changes to their positions in the business. Activest Wealth Management raised its position in shares of Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares in the last quarter. JPL Wealth Management LLC acquired a new stake in shares of Corteva during the 3rd quarter worth about $25,000. True Wealth Design LLC raised its position in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after acquiring an additional 264 shares in the last quarter. Garton & Associates Financial Advisors LLC acquired a new stake in shares of Corteva during the 4th quarter worth about $27,000. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of Corteva during the 4th quarter worth about $28,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.